Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (11-20 of 290) with videos related to

Pageof 29
Sort By:
Inflammatory Bowel Diseases|July 2, 2010
Immunosuppressant combined with infliximab in Crohn's Disease: for 6 months, for 2 years, or forever?Edouard Louis
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 27, 2019
ReplyBenjamin Pariente, Edouard Louis
Gastroenterologie Clinique Et Biologique|January 21, 2004
[Early obstructive colon after treatment of active refractory Crohn's disease with infliximab]Jacques Belaiche, Edouard Louis
The American Journal of Gastroenterology|December 21, 2002
Severe lower gastrointestinal bleeding in Crohn's disease: successful control with infliximabJacques Belaiche, Edouard Louis
Revue Medicale De Liege|June 23, 2023
[Functional colopathy : still relevant ? Let's move to irritable bowel syndrome]Pascale Latour, Edouard Louis
Best Practice & Research. Clinical Gastroenterology|March 6, 2003
Optimizing treatment with thioguanine derivatives in inflammatory bowel diseaseEdouard Louis, Jacques Belaiche
Frontiers in Medicine|May 24, 2021
Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020?Fernando Gomollón, Edouard Louis
Therapeutic Advances in Gastroenterology|May 17, 2023
Precision medicine and drug optimization in adult inflammatory bowel disease patientsSophie Vieujean, Edouard Louis
Gut|January 17, 2025
Challenge of treatment de-escalation in inflammatory bowel diseasesCatherine Reenaers, Edouard Louis
PET Clinics|May 10, 2016
The Role of PET/CT in the Monitoring and Diagnosis of Pediatric Inflammatory Bowel DiseaseRoland Hustinx, Edouard Louis
Pageof 29

Showing results (11-20 of 290) with videos related to

Sort By:
Pageof 29
Inflammatory Bowel Diseases|July 2, 2010
Immunosuppressant combined with infliximab in Crohn's Disease: for 6 months, for 2 years, or forever?Edouard Louis
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 27, 2019
ReplyBenjamin Pariente, Edouard Louis
Gastroenterologie Clinique Et Biologique|January 21, 2004
[Early obstructive colon after treatment of active refractory Crohn's disease with infliximab]Jacques Belaiche, Edouard Louis
The American Journal of Gastroenterology|December 21, 2002
Severe lower gastrointestinal bleeding in Crohn's disease: successful control with infliximabJacques Belaiche, Edouard Louis
Revue Medicale De Liege|June 23, 2023
[Functional colopathy : still relevant ? Let's move to irritable bowel syndrome]Pascale Latour, Edouard Louis
Best Practice & Research. Clinical Gastroenterology|March 6, 2003
Optimizing treatment with thioguanine derivatives in inflammatory bowel diseaseEdouard Louis, Jacques Belaiche
Frontiers in Medicine|May 24, 2021
Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020?Fernando Gomollón, Edouard Louis
Therapeutic Advances in Gastroenterology|May 17, 2023
Precision medicine and drug optimization in adult inflammatory bowel disease patientsSophie Vieujean, Edouard Louis
Gut|January 17, 2025
Challenge of treatment de-escalation in inflammatory bowel diseasesCatherine Reenaers, Edouard Louis
PET Clinics|May 10, 2016
The Role of PET/CT in the Monitoring and Diagnosis of Pediatric Inflammatory Bowel DiseaseRoland Hustinx, Edouard Louis
Pageof 29